Early effects of imatinib mesylate on the expression of insulin‐like growth factor binding protein‐3 and positron emission tomography in patients with gastrointestinal stromal tumor
Jonathan C. Trent(The University of Texas MD Anderson Cancer Center), Wei Zhang(Huaian First People’s Hospital)
Cited by 36
Related Papers
Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparticle-mediated synergistic metabolic therapy and chemotherapy for non-small cell lung cancer
|Journal of Nanobiotechnology|2021|106
Rare incidence of congestive heart failure in gastrointestinal stromal tumor and other sarcoma patients receiving imatinib mesylate
|Cancer|2009|80
MMP1 Overexpression Promotes Cancer Progression and Associates with Poor Outcome in Head and Neck Carcinoma
|Computational and Mathematical Methods in Medicine|2022|26